Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salma Elmallah

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|May 15, 2025
Computational Optimization and In Silico Analysis for the Discovery of New HER2 and CDK4/6 Drug Candidates for Breast CancerSalma Elmallah
IEEE Transactions on Bio-Medical Engineering|June 8, 2013
A flexible base electrode array for intraspinal microstimulationImad Khaled, Salma Elmallah, Cheng Cheng, et al.
International Journal of Pharmaceutics: X|May 1, 2024
A drug repurposing approach of Atorvastatin calcium for its antiproliferative activity for effective treatment of breast cancer: <i>In vitro</i> and <i>in vivo</i> assessmentDina M Gaber, Sherihan S Ibrahim, Ashraf K Awaad, et al.
Molecular Pharmacology|June 16, 2018
Lipophilicity of the Cystic Fibrosis Drug, Ivacaftor (VX-770), and Its Destabilizing Effect on the Major CF-causing Mutation: F508delStephanie Chin, Maurita Hung, Amy Won, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Anti-Cancer Agents in Medicinal Chemistry|May 15, 2025
Computational Optimization and In Silico Analysis for the Discovery of New HER2 and CDK4/6 Drug Candidates for Breast CancerSalma Elmallah
IEEE Transactions on Bio-Medical Engineering|June 8, 2013
A flexible base electrode array for intraspinal microstimulationImad Khaled, Salma Elmallah, Cheng Cheng, et al.
International Journal of Pharmaceutics: X|May 1, 2024
A drug repurposing approach of Atorvastatin calcium for its antiproliferative activity for effective treatment of breast cancer: <i>In vitro</i> and <i>in vivo</i> assessmentDina M Gaber, Sherihan S Ibrahim, Ashraf K Awaad, et al.
Molecular Pharmacology|June 16, 2018
Lipophilicity of the Cystic Fibrosis Drug, Ivacaftor (VX-770), and Its Destabilizing Effect on the Major CF-causing Mutation: F508delStephanie Chin, Maurita Hung, Amy Won, et al.
Pageof 1